Head-to-head · Cost-Efficiency Index
Bliv vs Boston Medical Group
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Bliv
Cost-first shoppers who want mainstream telehealth GLP-1 access.
Visit BlivBoston Medical Group
Cost-first shoppers who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate.
Visit Boston Medical GroupThe verdict
Bliv and Boston Medical Group tie on the Cost-Efficiency Index at 59/100, so neither wins outright on the numbers. For most shoppers we'd start with Bliv (ranked #264, a hair above #269) — Cost-first shoppers who want mainstream telehealth GLP-1 access. But Boston Medical Group is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Bliv.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Bliv | Boston Medical Group |
|---|---|---|
| Cost-Efficiency Index | 59/100 | 59/100 |
| Semaglutide / mo | $116/mo (as low as, varies by plan and eligibility, compounded) | $199/mo (starting strength, rising with dose, compounded) |
| Tirzepatide / mo | $199/mo (as low as, varies by plan and eligibility, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,392 | $2,388 |
| Tirzepatide / yr (modeled) | $2,388 | — |
| Coverage | Coverage not published | 7 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #264 | #269 |
Bliv
59/100Where the value is
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
The tradeoffs
- The advertised rates are 'as low as' figures footnoted 'based on plan structure and eligibility', and the plan selector sits behind the medical intake — the rate you are offered is not knowable before you hand over a medical history
- A $24.99 provider consultation fee is charged on top, and the refund policy deducts $200 for 'clinical coordination and account setup'
Regulatory note: the FDA issued a warning letter to Bliv Wellness LLC dba Bliv in February 2026. We still list and link to Bliv; you should know the letter is on the public record before you decide.
Boston Medical Group
59/100Where the value is
- An established medical group with a defined 12-week program rather than an open-ended subscription
- The price range and the 12-week total are both published, once you reach the costs page
- Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight
The tradeoffs
- The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
- The 12-week program totals $699 including a telemedicine platform fee that is never itemised — about $233/mo all-in, not $199
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.